DE3885031T2 - Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen. - Google Patents

Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen.

Info

Publication number
DE3885031T2
DE3885031T2 DE88112910T DE3885031T DE3885031T2 DE 3885031 T2 DE3885031 T2 DE 3885031T2 DE 88112910 T DE88112910 T DE 88112910T DE 3885031 T DE3885031 T DE 3885031T DE 3885031 T2 DE3885031 T2 DE 3885031T2
Authority
DE
Germany
Prior art keywords
water
soluble
cephem compounds
antibiotic preparation
soluble salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88112910T
Other languages
English (en)
Other versions
DE3885031D1 (de
Inventor
Kazuo Sakane
Nobuyoshi Yasuda
Shintaro Nishimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878718905A external-priority patent/GB8718905D0/en
Priority claimed from GB878721567A external-priority patent/GB8721567D0/en
Priority claimed from GB878725051A external-priority patent/GB8725051D0/en
Priority claimed from GB878729574A external-priority patent/GB8729574D0/en
Priority claimed from GB888801423A external-priority patent/GB8801423D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3885031D1 publication Critical patent/DE3885031D1/de
Publication of DE3885031T2 publication Critical patent/DE3885031T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DE88112910T 1987-08-10 1988-08-09 Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen. Expired - Fee Related DE3885031T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB878718905A GB8718905D0 (en) 1987-08-10 1987-08-10 Salts of new cephem compounds
GB878721567A GB8721567D0 (en) 1987-09-14 1987-09-14 Salts of cephem compounds
GB878725051A GB8725051D0 (en) 1987-10-26 1987-10-26 Salts of cephem compounds
GB878729574A GB8729574D0 (en) 1987-12-18 1987-12-18 Water-soluble antibiotic composition
GB888801423A GB8801423D0 (en) 1988-01-22 1988-01-22 Water-soluble antibiotic composition

Publications (2)

Publication Number Publication Date
DE3885031D1 DE3885031D1 (de) 1993-11-25
DE3885031T2 true DE3885031T2 (de) 1994-02-17

Family

ID=27516755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88112910T Expired - Fee Related DE3885031T2 (de) 1987-08-10 1988-08-09 Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen.

Country Status (16)

Country Link
US (1) US5104866A (de)
EP (1) EP0303223B1 (de)
JP (1) JP2625937B2 (de)
KR (1) KR970008127B1 (de)
AR (1) AR243380A1 (de)
AU (1) AU616677B2 (de)
CA (1) CA1338780C (de)
DE (1) DE3885031T2 (de)
DK (1) DK445188A (de)
ES (1) ES2059454T3 (de)
FI (1) FI89927C (de)
HU (2) HU210848B (de)
IE (1) IE61679B1 (de)
IL (1) IL87364A0 (de)
NO (1) NO175963C (de)
PT (1) PT88217B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100572323B1 (ko) 2003-12-11 2006-04-19 삼성전자주식회사 멀티레벨 고전압 발생장치
RS55365B1 (sr) * 2008-10-31 2017-03-31 Shionogi & Co Cefalosporin sa kateholskom grupom
IN2012CN09242A (de) 2010-04-05 2015-08-21 Shionogi & Co
JP5852559B2 (ja) * 2010-04-05 2016-02-03 塩野義製薬株式会社 擬似カテコール基を有するセフェム化合物
EA028342B1 (ru) 2011-09-09 2017-11-30 Мерк Шарп И Доум Корп. Способы лечения пневмонии
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
AU536842B2 (en) * 1978-12-29 1984-05-24 Fujisawa Pharmaceutical Co., Ltd. Cephalosporin antibiotics
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4563449A (en) * 1982-07-19 1986-01-07 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
IL77458A (en) * 1985-01-14 1990-07-26 Eisai Co Ltd Cephem derivatives,their production and antibacterial compositions containing them and certain novel intermediates therefor
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE3885031D1 (de) 1993-11-25
US5104866A (en) 1992-04-14
ES2059454T3 (es) 1994-11-16
NO175963C (no) 1995-01-11
PT88217A (pt) 1989-06-30
DK445188A (da) 1989-02-11
HU210848B (en) 1995-08-28
IE882365L (en) 1989-02-10
EP0303223A3 (en) 1990-11-28
IE61679B1 (en) 1994-11-16
PT88217B (pt) 1995-03-01
FI89927B (fi) 1993-08-31
EP0303223A2 (de) 1989-02-15
FI89927C (fi) 1993-12-10
CA1338780C (en) 1996-12-10
NO883530D0 (no) 1988-08-09
KR970008127B1 (ko) 1997-05-21
AU616677B2 (en) 1991-11-07
FI883696A0 (fi) 1988-08-09
DK445188D0 (da) 1988-08-09
FI883696A (fi) 1989-02-11
KR890003782A (ko) 1989-04-18
NO175963B (no) 1994-10-03
JPH01110690A (ja) 1989-04-27
AR243380A1 (es) 1993-08-31
HUT47943A (en) 1989-04-28
NO883530L (no) 1989-02-13
EP0303223B1 (de) 1993-10-20
IL87364A0 (en) 1989-01-31
AU2059888A (en) 1989-02-16
JP2625937B2 (ja) 1997-07-02
HU211940A9 (en) 1996-01-29

Similar Documents

Publication Publication Date Title
NO883722D0 (no) Fremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater.
BR8801089A (pt) Utilizacao de sistemas,sistemas e compostos
NO178726C (no) Vandig kalksuspensjon og fremstilling derav
DE3750355D1 (de) 23-Oxo(keto) und 23-Imino-Derivate von LL-F28249-Verbindungen.
NO865013L (no) Fremgangsmaate for fremstilling av antibakterielle kinolonderivater.
NO863942L (no) Aminosalter av lignosulfonater.
DE3885031D1 (de) Wasserlösliches antibiotisches Präparat und wasserlösliche Salze von Cephem-Verbindungen.
DE3678453D1 (de) Cephemderivate.
NO870126D0 (no) 7-(azabicykloalkyl)-chinolinkarboksylsyre- og naftyri-donkarboksylsyre-derivater.
DK256085D0 (da) Cephemforbindelser og salte og estere deraf, samt deres fremstilling og anvendelse
EP0238060A3 (en) Cephalosporin derivatives, processes for their preparation and antibacterial agents
FI864764A0 (fi) Foerfarande foer samtidig dimerisering av etylen och kopolymerisering av etylen med den dimeriserade produkten.
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
NO862687D0 (no) Fremstilling av antibakterielle quinolonkarboksylsyrederivater.
DE3889198D1 (de) Cephalosporinverbindungen und antibakterielle Mittel.
DK652887D0 (da) Beta-lactam-antibiotika
NO893143D0 (no) Fremstilling av klordioksyd.
ATE96027T1 (de) Wasserloesliches antibiotisches praeparat und wasserloesliche salze von cephem-verbindungen.
DK670388A (da) Antibiotikumholdigt farmaceutisk praeparat
NO885576D0 (no) Trometaminsalt av 1-metyl-beta-okso-alfa-(fenyl-karbamoyl)-2-pyrrolpropionitril.
ATE109150T1 (de) Mono- und diepoxid-derivate von ll-f28249- verbindungen.
IT8548062A1 (it) Antibiotici cefalosporinici e procedimento per la loro preparazione
DK503787A (da) Cephalosporinderivater
ZA885642B (en) Water-soluble antibiotic compositions and water-soluble salts of new cephem compounds
ATE65399T1 (de) Trockene schnell loesliche zusammensetzung von beta-lactam-antibiotika.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee